Summaries for patients. Cost-effective management of flu in adults older than 65 years of age.
D000081:Acetamides / Q000191:economics / Q000627:therapeutic use; D000368:Aged; D000547:Amantadine / Q000191:economics / Q000627:therapeutic use; D000998:Antiviral Agents / Q000191:economics* / Q000627:therapeutic use*; D003198:Computer Simulation; D003362:Cost-Benefit Analysis; D003661:Decision Support Techniques; D006146:Guanidines; D006801:Humans; D007251:Influenza, Human / Q000150:complications / Q000188:drug therapy* / Q000191:economics*; D053139:Oseltamivir; D011714:Pyrans; D019057:Quality-Adjusted Life Years; D012299:Rimantadine / Q000191:economics / Q000627:therapeutic use; D012680:Sensitivity and Specificity; D012794:Sialic Acids / Q000191:economics / Q000627:therapeutic use; D053243:Zanamivir
D000081:Acetamides; D000998:Antiviral Agents; D006146:Guanidines; D011714:Pyrans; D012794:Sialic Acids; D012299:Rimantadine; D053139:Oseltamivir; D000547:Amantadine; D053243:Zanamivir